AGS-1C4D4

BIOLOGICAL3 trials

Sponsors

Astellas Pharma Inc, Agensys, Inc.

Conditions

Carcinoma, Pancreatic DuctalPancreatic CancerPancreatic DiseaseProstate Cancer

Phase 1

AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

CompletedNCT00519233

Astellas Pharma IncProstate Cancer

Start: 2007-09-30End: 2009-09-30Updated: 2014-05-02

Phase 2

A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer

CompletedNCT00902291

Astellas Pharma IncCarcinoma, Pancreatic Ductal, Pancreatic Cancer, Pancreatic Disease

Start: 2009-04-30End: 2012-04-30Updated: 2015-09-14

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

CompletedNCT01608711

Agensys, Inc.Carcinoma, Pancreatic Ductal, Pancreatic Cancer, Pancreatic Disease

Start: 2012-08-07End: 2015-11-16Updated: 2017-05-16

Related Papers

Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.

2013-02-2832 citations